KAE609 (cipargamin)

cipargamin · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KAE609 (cipargamin), covering 2015-09-03 to 2015-09-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection [Phase 2]